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Background: Inguinal hernia repair is one of the most common surgical procedures worldwide. This procedure is
increasingly performed with endoscopic techniques (laparoscopy). Many surgeons prefer to cover the hernia gap
with a mesh to prevent recurrence. The mesh must be fixed tightly, but without tension. During laparoscopic
surgery, the mesh is generally fixed with staples or tissue glue. However, staples often cause pain at the staple sites,
and they can cause scarring of the abdominal wall, which can lead to chronic pain. We designed a trial that aims to
determine whether mesh fixation with glue might cause less postoperative pain than fixation with staples during a
transabdominal preperitoneal patch plastic repair.
Methods/Design: The TISTA trial is a prospective, randomized, controlled, single-center trial with a two-by-two
parallel design. All patients and outcome-assessors will be blinded to treatment allocations. For eligibility, patients
must be male, ≥18 years old, and scheduled for laparoscopic repair of a primary inguinal hernia. One group
comprises patients with a unilateral inguinal hernia that will be randomized to receive mesh fixation with either
tissue glue or staples. The second group comprises patients with bilateral inguinal hernias. They will be randomized
to receive mesh fixation with tissue glue either on the right or the left side and with staples on the other side. The
primary endpoint will be pain under physical stress, measured at 24 h after surgery. Pain will be rated by the patient
based on a numeric rating scale from 0 to 10, where 10 equals the worst pain imaginable. A total of 82 patients will
be recruited (58 patients with unilateral inguinal hernias and 24 patients with bilateral hernias). This number is
estimated to provide 90% power for detecting a pain reduction of one point on a numeric rating scale, with a
standard deviation of one.
Discussion: Patients with bilateral hernias will receive two meshes, one fixed with glue, and the other fixed with
staples. This design will eliminate the inter-individual bias inherent in comparing pain measurements between two
groups of patients.
Trial registration: ClinicalTrials.gov: NCT01641718
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Scientific background and explanation of rationale
Inguinal hernias are the most common hernia; they ac-
count for 90% of all spontaneous hernias. Moreover, in-
guinal hernia repair is the most frequently performed
procedure in general surgery. In Germany, more than
200,000 inguinal hernias are repaired annually [1,2]. The
standard method for repairing an inguinal hernia, origin-
ally described by Bassini in 1889, is to close the inguinal
canal with sutures. Due to the high recurrence rate with
this technique [3], new methods were established that
used tension-free implantation of synthetic meshes.
Furthermore, endoscopic/laparoscopic methods have
been introduced, where the hernia canal is typically
approached from the posterior side; this approach is dir-
ectly opposite to the anterior approach used in the open
surgery technique. Which of these approaches and
methods yields the better results is strongly debated [4].
Among the various posterior techniques employing pre-
peritoneal mesh implantation [2,5-7], the two most
widely accepted techniques are the transabdominal pre-
peritoneal patch plastic (TAPP) repair and the total
extraperitoneal (TEP) repair [8,9]. There are many indi-
cations for both techniques, but the TAPP repair is par-
ticularly recommended for recurrent hernias (after an
open preperitoneal patch plastic) and difficult hernias
(sliding or incarcerated hernias) [2,8,10]. The TAPP re-
pair has the advantage that it is easier to perform, can
be better standardized, and offers the possibility to per-
form a diagnostic laparoscopy [2]. Thus, the type of her-
nia can be assessed immediately on both sides of the
groin, and a bilateral repair can be performed without
additional incisions. In general, the TAPP repair is easier
to learn than the TEP repair [2,10,11]. Most randomized
studies that compared laparoscopic with open repair
found that laparoscopy was associated with less postop-
erative pain, earlier return to work, higher costs, a lon-
ger operating time, a longer learning period, and a
higher recurrence and complication rate during the early
learning phase [12-14]. In summary, open, mesh-based,
tension-free repair remains the standard procedure;
however, in the hands of a well-trained surgeon laparo-
scopic herniorrhaphy can produce excellent results com-
parable with those of open repair [14,15].
Many factors determine whether patients experience
postoperative pain, including the type of intervention, the
presence of complications, patient age, and individual
tolerance. In particular, the type of mesh fixation
employed for the hernioplasty has a strong influence on
postoperative pain [16,17]. In a recent review, mesh fix-
ation with glue was compared to mesh fixation with sta-
ples for an endoscopic inguinal hernia repair [18]. For
the TAPP repair, two randomized controlled trials
[19,20], one non-randomized trial [21], and two caseseries [22,23] were reviewed. The authors of the review
found less postoperative pain and more rapid recovery
after glue fixation than after staple fixation, without any
significant difference in the recurrence rate. Nevertheless,
the authors concluded that, due to the overall poor qual-
ity of the currently published data, future well-designed
studies are required to demonstrate the superiority of fi-
brin glue over mechanical stapling for mesh fixation.
Thus, well-designed, randomized studies that compare
glue and staple fixations for TAPP repair remain war-
ranted. Most previous studies applied only one mesh fix-
ation method for patients with bilateral hernias. Only one
study compared glue and staple fixations in single patients
with bilateral hernias [24]; interestingly, that study was not
included in the review by Schäfer et al. [18].
This study protocol describes a two-by-two trial design
that will be used to compare the two fixation methods
in two groups of randomized patients; one group with
unilateral hernias and the other group with bilateral her-
nias. The latter group will allow a comparison of the two
methods in a single patient. This design will eliminate
the inter-individual bias that may influence the unilateral
hernia group. This study focuses on early postoperative
pain, particularly during the first two postoperative days.
In many other studies, pain is first measured one month
after surgery.
Aim of the study
The aim of this trial is to investigate early and late post-
operative pain after laparoscopic hernia repair with the
TAPP technique, using either fibrin glue or staples for
mesh fixation.
Methods/Design
The study was planned according to the updated Con-
solidated Standards of Reporting Trials (CONSORT)
statement. The study design is in compliance with the
Declaration of Helsinki, the Guidelines of Good Clinical
Practice issued by ICH, and the requirements of Swiss
regulatory authorities [25-27].
Trial design
This trial is a double blind, randomized, controlled trial
with a two-by-two design, conducted at a single institu-
tion. The study aims to compare pain after mesh im-
plantation, when fixed either with staples or glue, in a
superiority analysis. The CONSORT diagram of the trial
is depicted in Figure 1.
Eligibility criteria and patient recruitment
Patients scheduled for elective laparoscopic primary
inguinal hernia repair at the Department of Surgery,
Kantonsspital St. Gallen, will be screened for enrollment
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Figure 1 Consort diagram of the TISTA trial.
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the patient meets the eligibility criteria.
Patients that match the following criteria are eligible
for inclusion in the clinical trial:
 age, 18 years or older
 male gender
 primary hernia repair (no re-operations for a
recurrent hernia)
 no chronic pain
 no acute pain that requires analgesics, other than
paracetamol or more than a single dose of
non-steroidal anti-inflammatory drug treatment
within 48 h before surgery
 no current treatment with psychopharmaceutical
drugs
 good compliance can be expected
 no mental incapacity
 no known incompatibility (allergies) with Tisseel
compounds
 informed consent
Under the following circumstances, patients will be ex-
cluded from the trial: hernia is inoperable with TAPP, due to the size,
previous abdominal surgery (assuming a damaged
peritoneum), or expected adhesions
 repair requires an intra-operative change to another
hernia repair technique (e.g. open access methods)
 the patient wishes to stop further trial participation
When the patient refuses further participation after re-
ceiving surgery, the patient will receive a safety check-up
during a one-month follow-up. Otherwise, the patient
will not receive the study treatment and will not require
a study-related safety follow-up.
Study objectives and endpoints
The primary objective of this trial is to show that after
TAPP repair for unilateral and bilateral inguinal hernias
the acute postoperative pain caused by mesh fixation
with tissue glue is less than with staple fixation.
The primary efficacy endpoint of the TISTA trial is
pain under physical stress at 24 h after surgery. Pain will
be rated by the patient using a numeric rating scale
(NRS). The NRS ranges from 0 to 10 in steps of one,
with 0 representing no pain at all and 10 the worst im-
aginable pain. The NRS is comparable to the visual
analogue scale (VAS) where the degree of pain is marked
on a 10 cm long line. In practical terms, average NRS
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The patient is first asked to rate the pain at rest and
then to rate it after physical stress. Physical stress is in-
duced by a 90° bending of the hip joint on the operated
side(s). The secondary endpoints of the trial and their
definitions are summarized in Table 1.
Standardization of treatments
Patient intra- and peri-operative care will be standard-
ized and maintained identical for each patient, except
for the mesh fixation technique. The patients will receive
combined neuraxial and general anesthesia.
Transabdominal preperitoneal patch plastic repair (TAPP)
The abdomen will be accessed and the pneumoperito-
neum will be achieved with standard laparoscopic tech-
niques. The preperitoneal space will be exposed
transabdominally with a sharp incision, followed byTable 1 Secondary endpoints and definitions
Secondary endpoints Definitions




Operating time Time, in min
Length of hospital stay Time, in day
Postoperative analgesic requirements Amount (g/
after surgery
















Time to return to normal activities Time, in day
Relapse Within 1 yea





an averabluntly stripping the peritoneum that overlies the in-
guinal anatomy. An Ultrapro® mesh (Ethicon Inc.,
Johnson & Johnson, Somerville, NJ, USA) will be de-
ployed and fixed in place with either staples or glue, and
then the peritoneum will be returned to its anatomical
position.
Surgical technique
At an umbilical site, a Veress needle is inserted to induce
a pneumoperitoneum, and then the needle is replaced
with a 10 to 12 mm optical trocar. Next, two 5 mm tro-
cars are positioned bilaterally on the umbilical line in
the iliac fossa. An incision is made in the peritoneal wall,
starting at the level of the superior margin of the in-
ternal inguinal ring and at the level of the epigastric ves-
sels. The incision is extended medially, up to the residue
of the umbilical artery, and then laterally, 3 to 4 cm past
the inguinal ring; the total incision length is 7 to 8 cm.n a numeric rating scale from 0-10 at rest and upon bending the hip
operated side
utes, from the first skin incision to the application of dressing
s (with one decimal precision), from start of surgery to hospital release
day) and type (paracetamol, metamizole, morphine) of analgesic required
, before hospital discharge
fined as:
ence of intermittent hyperesthesia, burning sensation, or jabbing pain in
teral, inguinal area nerves (genitofemoral nerve, lateral cutaneous
nerve, ilioinguinal and iliohypogastric nerve) [20,22,27]
n will be performed 14 days, 1, 3 and 12 months after surgery
ree of pain will measured as described above
according to Dindo et al [28], and it includes:
infection, defined as infections treated without further surgery and
d by clinical examination without microbiological confirmation
ma or seroma formation, identified by clinical examination alone,
ischarge from hospital, which does not require radiological confirmation
ation, defined as the need for re-operation during the initial hospital stay
retention, urinary tract infection
ry infection
ous deviation from the normal postoperative course
s, from hospital discharge to first working day
r of surgery
ased on the following factors:
glue, staples, and instruments to apply glue or staples
nt: cost for excess operating time for the “slower” mesh fixation
of hospital stay (cost/day)
leave of absence (converted into a monetary amount based on
ge salary)
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ectly isolated and reduced. In the case of an indirect or
femoral hernia, the preperitoneal parapubic adipose tis-
sue is carefully dissected medially to expose the hori-
zontal pubic ramus and Cooper’s ligament. Accurate
dissection of the preperitoneal retrovesical tissue facili-
tates positioning the mesh. The internal inguinal ring is
explored, and the hernial sac is isolated and reduced;
this maneuver is performed to reveal the presence of
perihernial lipomas, which can then be removed. Once
the spermatic cord is freed from the peritoneal wall, a
macroporous, partially absorbable Ultrapro mesh (Ethi-
con) is positioned. This type of mesh allows the surgeon
to view the underlying structures, which facilitates posi-
tioning the mesh. The mesh is cut to 10 × 13 cm and
placed in the preperitoneal space such that it is in med-
ial contact with the paravesical area, it covers Cooper’s
ligament, it rests on the inguinal region, and it extends
laterally over the epigastric vessels.
Stapling
For this procedure, the mesh is fixed with an Endopath
Multifeed Stapler with a 10 mm shaft and helical titan-
ium staples (Protack, Covidien, Mansfield, MA, USA).
The technique that we adopted involves positioning two
metal clips at the level of Cooper’s ligament and the
pubic tubercle. Additionally 4 staples are placed laterally
at the level of the deep inguinal ring medially and lat-
erally to the inferior epigastric vessels with absorbable
staples (Securestrap, Ethicon). The peritoneal flap is then
closed with four additional absorbable staples.
Tisseel™ tissue glue
For this procedure, the mesh is anchored with 2 mL of fi-
brin glue (Tisseel, Baxter, Deerfield, IL, USA). Tisseel is
applied to both anterior and posterior sides of the mesh
with a dedicated laparoscopic tool (Duplotip, Baxter)
inserted into a 5 mm trocar. To obtain optimal bonding
between the Tisseel on the mesh and the peritoneal wall,
slight pressure is applied to the mesh with the Duplotip.
The Tisseel is applied to the entire perimeter of the mesh,
and in particular, at the level of the superior margin, the
“triangle of disaster,” in proximity of the prevesical fat, to
assure good adhesion. The peritoneal flap is then closed
with small, continuous, absorbable 2/0 sutures.
Postoperative care
To reduce bias, the postoperative regime is standardized
for the study. All patients will receive the same intra-
and perioperative care, except for the mesh fixation
technique. The postoperative care will also be uniformly
administered, and changes will only be made when the
patient’s comfort or safety is compromised. All patients
will be mobilized as soon as possible during thepostoperative period. All patients will receive paraceta-
mol (three 1 g doses per 24 h), administered either intra-
venously (early postoperative course) or orally (late
postoperative course).
Additional analgesia will be provided as required ac-
cording to the following scheme:
 First line reserve: metamizole, maximum 4 g/24 h
 Second line reserve (if necessary): morphine,
1-2 mg, delivered intravenously
The use of additional analgesics will be documented.
Trial interventions
Patients will be randomized according to the following
scheme:
Primary arm 1: Patients with a unilateral inguinal
hernia
secondary arm 1: mesh fixation with tissue glue
secondary arm 2: mesh fixation with staples
Primary arm 2: Patients with bilateral inguinal hernias
secondary arm 1: right side, tissue glue; left side,
staples
secondary arm 2: right side, staples; left side, tissue
glue
Methods for reducing bias
The patients will be randomly assigned to the treatment,
and the patients will be blinded to the assigned treat-
ment. In primary arm 2 (patients with bilateral hernias),
the bias of individual pain perception can be eliminated,
because a single individual decides (blindly) which side
is more painful.
The treatment assignment will be based on a block
randomized list (one for each primary arm) with variable
block sizes (between 2 and 6 patients per block). After
each patient signed the informed consent, his name will
be entered into the study database. At the beginning of
surgery, the patients scheduled for unilateral repair will
be examined laparoscopically to determine whether the
other side also requires repair. The final decision for
uni- or bilateral repair can only be made after this intra-
operative examination. Thus, randomization will occur
during surgery by contacting the study nurse to receive
the treatment allocation. In the absence of the study
nurse, the data manager can provide the allocation infor-
mation. The data manager generates the randomization
list and maintains a secured copy of the assignment list.
The pain scores are obtained by nurses or physicians
that are not aware of the treatment assignment (observer
blinding).
In the case of unforeseen postoperative complications,
the treating physician (surgeon) will know the treatment
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the data manager can unblind the assignment when ne-
cessary. Any unblinding will be recorded in the study
documentation.
Sample size calculation
The sample size was calculated under the hypothesis
that either glue fixation or staple fixation is superior for
the primary endpoint (= pain after 24 h)(two-sided ana-
lysis). Lovisetto reported a mean VAS pain score of 1.9
for glue fixation and 2.6 for staple fixation one month
after TAPP repair [19]. The observed difference of 0.7 is
usually considered to be of no clinical relevance. We
thus assumed a difference of 1 as a clinically relevant
difference. Standard deviation was estimated to be equal
1, resulting in a standardized effect size of 1 which gen-
erally is considered clinically relevant. The sample size
calculation was performed as two-sided analysis with a
type I error of α = 0.05 and a power of (1-β) = 0.90.
Based on these assumptions, we calculated that 23 pa-
tients per arm would be required for unilateral hernias
(t-test for two independent samples with common vari-
ance). Assuming a drop-out rate of 20%, the total num-
ber of patients needed per arm is 29, resulting in a total
of 58 patients with unilateral hernias. For the second
arm with bilateral hernias we calculated that 19 patients
would be required (t-test for paired samples), assuming
an intra-individual correlation of 0.2 (derived from a
preliminary, unpublished analysis of patients with bilat-
eral inguinal hernias that had undergone a Lichtenstein
procedure). With a drop-out rate of 20%, a total of 24
patients with bilateral hernias would be required, result-
ing in a total of 82 patients for the entire study.
With an annual case load of approximately 100 in the
previous years, we estimate that patient recruitment
should be achieved within one or two years.
Statistical analysis
The statistical analysis will be performed with SPSS
Statistics for Windows (IBM Corp., Armornk, NY, USA).
A two-sided p-value <0.05 will be considered statistically
significant. Descriptive statistics will be used to analyze
the baseline characteristics. For the superiority analysis of
pain intensity at 24 h after surgery, the Mann−Whitney U
and Wilcoxon tests will be applied, as appropriate. To
adjust for multiple testing, the Hochberg procedure will
be applied [29].
Pain measurements performed at 4, 8, 12, 24, 36, 48 h
after surgery by patients with unilateral and bilateral
hernias will be analyzed in one mixed model to assess
the mean ranks of the NRS scores with adjustments for
time, treatment, and unilateral versus bilateral hernias.
To compare other continuous secondary endpoints (e.g.,
operating time, length of hospital stay, postoperativeadministered analgesics, time to return to normal activ-
ity, and economic impact), the Mann−Whitney U and
Wilcoxon tests will be applied, as appropriate. Chi-
square statistics will be used to compare categorical sec-
ondary endpoints (e.g., incidence of chronic pain, rate of
recurrence, and postoperative morbidity). Auxiliary,
non-confirmatory analyses will be performed to assess
the influences of baseline patient characteristics and
treatment characteristics on the primary and secondary
outcomes.
Intermittent missing values will be replaced by linear
interpolation (e.g. post-operative pain values within 48 h
after surgery). No interim analysis is planned for this
study. Data from patients withdrawn from the study will
be disregarded, unless exclusion is based on a postopera-
tive patient request, and the patient agrees to the use of
existing documented data.
The confirmatory analysis will be performed based on
an intention-to-treat (ITT) design, and it will adhere to
ITT principles. When a protocol violation occurs, a per
protocol analysis (PP) will be performed for comparison.Ethical and legal considerations
This study will be conducted in agreement with either
the Declaration of Helsinki (Tokyo, Venice, Hong Kong,
Somerset West, and Edinburgh amendments) or the
local laws and regulations of the country, whichever pro-
vides the greatest protection for the patient. This proto-
col, the patient information sheet, and the patient
consent form have been reviewed and approved by the
local Ethics Committee (EKSG 12/080) and by Swissme-
dic (TpP_I_2012_003) prior to enrolling any patients in
this trial.
All patients will be informed of the aims of the study,
the possible adverse events, the procedures and possible
hazards to which they will be exposed, and the mechan-
ism of treatment allocation. They will be informed about
the strict confidentiality of their patient data and told
that their medical records may be reviewed for trial pur-
poses by authorized individuals other than their treating
physician. The signed consent document will be main-
tained by the investigator. A copy of the signed consent
document will be given to the patient or the patient’s le-
gally authorized representative.
It will be emphasized that participation is voluntary,
that the patient is allowed to refuse further participation
in the study at any time, and that any refusal will not in-
fluence the patient’s subsequent care. Documented in-
formed consent must be obtained for all patients
included in the study before they are registered or ran-
domized in the study. Registration and randomization
will be conducted in accordance with the national and
local regulatory requirements.
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of the investigator. During the trial, the patients will be
identified solely based on an individual identification
code. The trial findings will be stored in accordance with
local data protection law/ICH GCP Guidelines, and they
will be handled in the strictest confidence. For the pro-
tection of these data, organizational procedures have
been implemented to prevent distribution of the data to
unauthorized individuals.
The investigator will maintain a personal subject iden-
tification list (screening numbers with the corresponding
subject names) to ensure the records can be identified
when necessary.
Discussion
This study was designed as a randomized trial with a two-
by-two, parallel design. We aimed to compare patients
with unilateral hernias that received mesh implants, fixed
with either tissue glue or staples and to evaluate patients
with bilateral hernias that received mesh implants fixed
with tissue glue on one side and staples on the other side.
In the latter group, the same patient will rate the pain as-
sociated with both methods; these ratings will not be influ-
enced by inter-individual biases present in the unilateral
hernia arm. To further reduce biases, both patients and
observers (staff evaluating the pain) will be blinded to the
assigned treatment.
We expect that mesh implants fixed with tissue glue
will be associated with less postoperative pain, shorter
hospital stay, and a shorter sick leave after the operation
compared to implants fixed with staples. In addition to
enhancing patient comfort, the tissue glue fixation will
also have an economic impact, by reducing health care
costs. Because we can evaluate both inter-individual and
intra-individual biases in pain perception, this study will
provide important insights for future studies that aim to
investigate pain. This study will therefore provide novel
information that is currently lacking in the literature.
Trial status
The trial began on February 1st, 2013, and recruitment is
ongoing.
Abbreviations
CONSORT: Consolidated Standards of Reporting Trials; GCP: Good clinical
practice; ICH: International Conference on Harmonisation; ITT: Intention to
treat; NRS: Numeric rating scale (for pain measurement); PP: Per protocol;
TAPP: Transabdominal preperitoneal patch plastic; TEP: Total extraperitoneal
(repair); TISTA: This study’s acronym (TIsseel versus STAples); VAS: Visual
analogue scale (for pain measurement).
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SAM and IT developed the original study design. SAM, UB, and IT developed
the research protocol. RW and IT performed the sample size calculations.
SAM, BMS, CL, and IT are responsible for the clinical input. SAM, RW, IT, and
UB drafted the manuscript. All authors have approved the final manuscript.Acknowledgements
This trial is supported by a grant from the Clinical Trial Unit of the
Kantonsspital St. Gallen.
Author details
1Department of Surgery, Kantonsspital St.Gallen, CH-9007 St. Gallen,
Switzerland. 2Institute of Medical Biometry and Informatics, University of
Heidelberg, D-69120 Heidelberg, Germany. 3Department of Surgery,
Heidelberg University Hospital, D-69120 Heidelberg, Germany.
Received: 25 November 2013 Accepted: 10 March 2014
Published: 1 April 2014References
1. Fitzgibbons RJ Jr, Camps J, Cornet DA, Nguyen NX, Litke BS, Annibali R,
Salerno GM: Laparoscopic inguinal herniorrhaphy. Results of a
multicenter trial. Ann Surg 1995, 221:3–13.
2. Gass M, Banz VM, Rosella L, Adamina M, Candinas D, Guller U: TAPP or TEP?
Population-based analysis of prospective data on 4,552 patients
undergoing endoscopic inguinal hernia repair. World J Surg 2012,
36:2782–2786.
3. Suradom C, Palaphun J: The usage of two umbrella made-mesh plugs in
herniorrhaphy: comparative study with Bassini and Lichtenstein method.
J Med Assoc Thai 2011, 94:1373–1379.
4. Reuben B, Neumayer L: Surgical management of inguinal hernia. Adv Surg
2006, 40:299–317.
5. Camps J, Nguyen N, Annabali R, Fitzgibbons RJ Jr: Laparoscopic inguinal
herniorrhaphy: transabdominal techniques. Int Surg 1995, 80:18–25.
6. Campanelli G, Canziani M, Frattini F, Cavalli M, Agrusti S: Inguinal hernia:
state of the art. Int J Surg 2008, 6(Suppl 1):S26–S28.
7. Arregui ME, Young SB: Groin hernia repair by laparoscopic techniques:
current status and controversies. World J Surg 2005, 29:1052–1057.
8. Bittner R, Schwarz J: Inguinal hernia repair: current surgical techniques.
Langenbecks Arch Surg 2012, 397:271–282.
9. Bittner R, Arregui ME, Bisgaard T, Dudai M, Ferzli GS, Fitzgibbons RJ, Fortelny
RH, Klinge U, Kockerling F, Kuhry E, Kukleta J, Lomanto D, Misra MC,
Montgomery A, Morales-Conde S, Reinpold W, Rosenberg J, Sauerland S,
Schug-Pass C, Singh K, Timoney M, Weyhe D, Chowbey P: Guidelines for
laparoscopic (TAPP) and endoscopic (TEP) treatment of inguinal hernia
[International Endohernia Society (IEHS)]. Surg Endosc 2011, 25:2773–2843.
10. Leibl BJ, Jager C, Kraft B, Kraft K, Schwarz J, Ulrich M, Bittner R: Laparoscopic
hernia repair–TAPP or/and TEP? Langenbecks Arch Surg 2005, 390:77–82.
11. McCormack K, Wake B, Perez J, Fraser C, Cook J, McIntosh E, Vale L, Grant A:
Laparoscopic surgery for inguinal hernia repair: systematic review of
effectiveness and economic evaluation. Health Technol Assess 2005,
9:1–203. iii-iv.
12. Memon MA, Cooper NJ, Memon B, Memon MI, Abrams KR: Meta-analysis
of randomized clinical trials comparing open and laparoscopic inguinal
hernia repair. Br J Surg 2003, 90:1479–1492.
13. McCormack K, Scott NW, Go PM, Ross S, Grant AM: Laparoscopic
techniques versus open techniques for inguinal hernia repair. Cochrane
Database Syst Rev 2003:CD001785.
14. Neumayer L, Giobbie-Hurder A, Jonasson O, Fitzgibbons R Jr, Dunlop D,
Gibbs J, Reda D, Henderson W: Open mesh versus laparoscopic mesh
repair of inguinal hernia. N Engl J Med 2004, 350:1819–1827.
15. Kuhry E, van Veen RN, Langeveld HR, Steyerberg EW, Jeekel J, Bonjer HJ:
Open or endoscopic total extraperitoneal inguinal hernia repair? A
systematic review. Surg Endosc 2007, 21:161–166.
16. Nowobilski W, Dobosz M, Wojciechowicz T, Mionskowska L: Lichtenstein
inguinal hernioplasty using butyl-2-cyanoacrylate versus sutures.
Preliminary experience of a prospective randomized trial. Eur Surg Res
2004, 36:367–370.
17. Topart P, Vandenbroucke F, Lozac'h P: Tisseel versus tack staples as mesh
fixation in totally extraperitoneal laparoscopic repair of groin hernias: a
retrospective analysis. Surg Endosc 2005, 19:724–727.
18. Schäfer M, Vuilleumier H, Di Mare L, Demartines N: Fibrin sealant for mesh
fixation in endoscopic inguinal hernia repair: is there enough evidence
for its routine use? Surg Laparosc Endosc Percutan Tech 2010, 20:205–212.
19. Lovisetto F, Zonta S, Rota E, Mazzilli M, Bardone M, Bottero L, Faillace G,
Longoni M: Use of human fibrin glue (Tissucol) versus staples for mesh
Müller et al. BMC Surgery 2014, 14:18 Page 8 of 8
http://www.biomedcentral.com/1471-2482/14/18fixation in laparoscopic transabdominal preperitoneal hernioplasty: a
prospective, randomized study. Ann Surg 2007, 245:222–231.
20. Olmi S, Scaini A, Erba L, Guaglio M, Croce E: Quantification of pain in
laparoscopic transabdominal preperitoneal (TAPP) inguinal hernioplasty
identifies marked differences between prosthesis fixation systems.
Surgery 2007, 142:40–46.
21. Ceccarelli G, Casciola L, Pisanelli MC, Bartoli A, Di Zitti L, Spaziani A,
Biancafarina A, Stefanoni M, Patriti A: Comparing fibrin sealant with staples
for mesh fixation in laparoscopic transabdominal hernia repair: a case
control-study. Surg Endosc 2008, 22:668–673.
22. Olmi S, Erba L, Bertolini A, Scaini A, Croce E: Fibrin glue for mesh fixation
in laparoscopic transabdominal preperitoneal (TAPP) hernia repair:
indications, technique, and outcomes. Surg Endosc 2006, 20:1846–1850.
23. Santoro E, Agresta F, Buscaglia F, Mulieri G, Mazzarolo G, Bedin N, Mulieri M:
Preliminary experience using fibrin glue for mesh fixation in 250
patients undergoing minilaparoscopic transabdominal preperitoneal
hernia repair. J Laparoendosc Adv Surg Tech A 2007, 17:12–15.
24. Boldo E, Armelles A, Perez de Lucia G, Martin F, Aracil JP, Miralles JM,
Martinez D, Escrig J: Pain after laparascopic bilateral hernioplasty: early
results of a prospective randomized double-blind study comparing fibrin
versus staples. Surg Endosc 2008, 22:1206–1209.
25. Schulz KF, Altman DG, Moher D: CONSORT 2010 Statement: updated
guidelines for reporting parallel group randomised trials. Trials 2010,
11:32.
26. WMA Declaration of Helsinki - Ethical Principles for Medical Research
Involving Human Subjects. [http://www.wma.net/en/30publications/
10policies/b3/index.html]
27. Guideline For Good Clinical Practice E6(R1). [http://www.ich.org/
fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6_R1/Step4/
E6_R1__Guideline.pdf]
28. Dindo D, Demartines N, Clavien PA: Classification of surgical
complications: a new proposal with evaluation in a cohort of 6336
patients and results of a survey. Ann Surg 2004, 240:205–213.
29. Hochberg Y: A sharper Bonferroni procedure for multiple tests of
significance. Biometrika 1988, 75:800–802.
doi:10.1186/1471-2482-14-18
Cite this article as: Müller et al.: Use of human fibrin glue (Tisseel) versus
staples for mesh fixation in laparoscopic transabdominal preperitoneal
hernioplasty (TISTA): a randomized controlled trial (NCT01641718). BMC
Surgery 2014 14:18.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
